New for 2019, the tool includes the CDC’s extramural global activities around antibiotic resistance and showcases successes that came after Congress’ investment in the agency’s antibiotic resistance solutions initiative.
The antibiotic resistance investment map includes:
- Global and domestic extramural collaborations to identify and implement innovative solutions to protect people from the threat of antibiotic resistance.
- Over 170 state-reported successes, such as containing rare resistant germs to protect communities and prevent the spread of harmful germs.
- Printable global-, state-, and city-specific fact sheets showing how the CDC invests in activities in that area.
Click here to view the map.
More articles on clinical leadership and infection control:
1 in 4 antibiotic prescriptions are unnecessary, study finds
84% of patients receive antibiotics for infection-like symptoms, survey finds
WHO internal probe targets claims it misspent money for Ebola response
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.